Results 101 to 110 of about 2,500,398 (351)
European Respiratory Journal, 2019 The function of the right ventricle determines the fate of patients with pulmonary hypertension. Since right heart failure is the consequence of increased afterload, a full physiological description of the cardiopulmonary unit consisting of both the ...
A. Vonk Noordegraaf +9 more
semanticscholar +1 more source
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
Pulmonary Circulation, 2020 The COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary hypertension. The COVID-19 pandemic has altered routine standard of care practice and the acute management particularly for those patients with pulmonary ...
J. Ryan +6 more
semanticscholar +1 more source
Arthritis Care &Research, EarlyView.Objective We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source
Progressive pulmonary hypertension in cyanotic congenital heart disease with severe pulmonary stenosis [PDF]
, 1996 We report the progressive development of pulmonary hypertension despite the presence of severe pulmonary stenosis in three patients with cyanotic congenital heart disease. The associated intracardiac lesions were complete transposition with a ventricular
Cheung, YF, Leung, MP, Wang, EP
core +1 more source
An overview of the 6th World Symposium on Pulmonary Hypertension
European Respiratory Journal, 2019 Since 1973 the World Symposia on Pulmonary Hypertension (WSPH) proceedings have summarised the scientific advances and future needs in this field through the efforts of multiple task forces, each focusing on a different aspect of pulmonary hypertension ...
N. Galiè +3 more
semanticscholar +1 more source
Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?
Pulmonary Circulation, 2020 Evelyn M. Horn, Murali Chakinala, Ronald Oudiz, Elizabeth Joseloff and Erika B. Rosenzweig Advanced Heart Failure & Pulmonary Vascular Disease Programs, Weill Cornell Medicine, New York Presbyterian Hospital, New York, USA; Division of Pulmonary ...
E. Horn +4 more
semanticscholar +1 more source
Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes
Advanced Functional Materials, EarlyView.Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth +2 more
wiley +1 more source
Micro-CT Image-Derived Metrics Quantify Arterial Wall Distensibility Reduction in a Rat Model of Pulmonary Hypertension [PDF]
, 2000 We developed methods to quantify arterial structural and mechanical properties in excised rat lungs and applied them to investigate the distensibility decrease accompanying chronic hypoxia-induced pulmonary hypertension. Lungs of control and hypertensive
Dawson, Christopher A +4 more
core +1 more source
Three-dimensional echocardiography and 2D-3D speckle tracking imaging in chronic pulmonary hypertension. diagnostic accuracy in detecting hemodynamic signs of RV failure [PDF]
, 2015 Background and objective. Our aim was to compare three-dimensional (3D) and 2D and 3D speckle tracking (2D-STE, 3D-STE) echocardiographic parameters with conventional right ventricular (RV) indexes in patients with chronic pulmonary hypertension (PH ...
Alessia, Azzano +11 more
core +1 more source
Apelin and Pulmonary Hypertension [PDF]
Pulmonary Circulation, 2011 Pulmonary arterial hypertension (PAH) is a devastating disease characterized by pulmonary vasoconstriction, pulmonary arterial remodeling, abnormal angiogenesis and impaired right ventricular function. Despite progress in pharmacological therapy, there is still no cure for PAH.
Andersen, Charlotte Uggerhøj +4 more
openaire +2 more sources